In patients with diabetic macular edema, small gauge pars plana vitrectomy should be considered as a first-line treatment, ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Oral BI 1815368 from Boehringer Ingelheim aims to ...

Although corticosteroids were found to immediately improve best-corrected visual acuity and central macular thickness, anti–vascular endothelial growth factor (anti-VEGF) therapies had significant ...

Diabetic macular edema treatment options include anti-vascular endothelial growth factor (anti-VEGF) injections and laser therapy, with patient-specific factors guiding the best approach. What are the ...

A recent study published in the journal Nature Medicine showed that targeting senescent cells in the retina can be a lasting disease-modifying treatment for diabetic macular edema (DME). The retina is ...

The optic cup and macula of a 24-year-old female. Image is released to Wikimedia commons with patient consent. Imaged with a non-mydriatic fundus camera at Pacific University College of Optometry.

No overall change in retinal thickening with tonabersat but thicker retinas appeared to be ...

In both studies, Vabysmo was found to be noninferior to aflibercept, with average vision gains being comparable between the treatment groups. The Food and Drug Administration (FDA) has approved ...

Sunir J. Garg, MD, shares his recent experience at the American Academy of Ophthalmology Annual Meeting in San Francisco and highlights two key takeaways. First, Dr Garg explores the ...

Clearside Biomedical, Inc. announced that the Chinese Center for Drug Evaluation has accepted Arctic Vision's New Drug Application (NDA) for ARCATUS®, a treatment for uveitic macular edema (UME), for ...

Share on Pinterest The FDA has approved biosimilars for macular degeneration treatment. recep-bg/Getty Images The FDA approved two biosimilars for Eylea (aflibercept), a drug used to treat age-related ...